Oscar Health (OSCR) Set to Announce Earnings on Thursday

Oscar Health (NYSE:OSCRGet Rating) will be releasing its earnings data after the market closes on Thursday, August 11th. Analysts expect Oscar Health to post earnings of ($0.73) per share for the quarter. Individual interested in participating in the company’s earnings conference call can do so using this link.

Oscar Health (NYSE:OSCRGet Rating) last posted its earnings results on Tuesday, May 10th. The company reported ($0.36) EPS for the quarter, beating analysts’ consensus estimates of ($0.40) by $0.04. The firm had revenue of $972.77 million during the quarter, compared to the consensus estimate of $803.04 million. Oscar Health had a negative return on equity of 37.23% and a negative net margin of 22.93%. During the same period in the prior year, the company earned ($0.98) EPS. On average, analysts expect Oscar Health to post $-3 EPS for the current fiscal year and $-2 EPS for the next fiscal year.

Oscar Health Stock Down 1.7 %

Shares of OSCR opened at $6.32 on Wednesday. The company has a market cap of $1.33 billion, a PE ratio of -2.36 and a beta of 1.31. The business has a fifty day moving average of $4.91 and a 200 day moving average of $6.56. Oscar Health has a 52-week low of $3.89 and a 52-week high of $18.89. The company has a quick ratio of 1.20, a current ratio of 1.20 and a debt-to-equity ratio of 0.22.

Insider Activity

In related news, CFO Richard Scott Blackley sold 19,546 shares of the stock in a transaction dated Monday, June 6th. The stock was sold at an average price of $5.01, for a total transaction of $97,925.46. Following the transaction, the chief financial officer now owns 264,307 shares of the company’s stock, valued at approximately $1,324,178.07. The transaction was disclosed in a filing with the SEC, which is available through this hyperlink. In related news, EVP Alessandrea C. Quane sold 11,300 shares of the firm’s stock in a transaction that occurred on Monday, June 6th. The stock was sold at an average price of $5.01, for a total transaction of $56,613.00. Following the transaction, the executive vice president now owns 131,018 shares in the company, valued at approximately $656,400.18. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CFO Richard Scott Blackley sold 19,546 shares of the stock in a transaction that occurred on Monday, June 6th. The stock was sold at an average price of $5.01, for a total value of $97,925.46. Following the sale, the chief financial officer now directly owns 264,307 shares of the company’s stock, valued at $1,324,178.07. The disclosure for this sale can be found here.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in OSCR. Bank of America Corp DE lifted its stake in shares of Oscar Health by 768.1% in the first quarter. Bank of America Corp DE now owns 220,810 shares of the company’s stock worth $2,202,000 after acquiring an additional 195,375 shares in the last quarter. Charles Schwab Investment Management Inc. increased its holdings in Oscar Health by 2.5% in the first quarter. Charles Schwab Investment Management Inc. now owns 193,504 shares of the company’s stock valued at $1,930,000 after buying an additional 4,801 shares during the last quarter. Swiss National Bank grew its holdings in shares of Oscar Health by 8.6% during the first quarter. Swiss National Bank now owns 103,100 shares of the company’s stock valued at $1,028,000 after purchasing an additional 8,200 shares during the last quarter. Ergoteles LLC bought a new position in shares of Oscar Health during the first quarter valued at approximately $633,000. Finally, Invesco Ltd. bought a new position in shares of Oscar Health during the first quarter valued at approximately $353,000. Institutional investors and hedge funds own 98.65% of the company’s stock.

Analysts Set New Price Targets

Several equities analysts have recently commented on the company. Bank of America lowered Oscar Health from a “neutral” rating to an “underperform” rating and cut their price target for the company from $6.00 to $4.50 in a research note on Wednesday, June 15th. Morgan Stanley lowered their price target on Oscar Health from $18.00 to $12.00 and set an “overweight” rating for the company in a report on Thursday, June 9th. Two investment analysts have rated the stock with a sell rating, two have given a hold rating and two have given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of “Hold” and an average price target of $9.50.

Oscar Health Company Profile

(Get Rating)

Oscar Health, Inc provides health insurance products and services in the United States. The company offers Individual & Family, Small Group, and Medicare Advantage plans, as well as +Oscar, a technology driven platform designed to help providers and payor clients to engage with members and patients.

Further Reading

Earnings History for Oscar Health (NYSE:OSCR)

Receive News & Ratings for Oscar Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oscar Health and related companies with MarketBeat.com's FREE daily email newsletter.